Increasing Number of heart failure cases is expected to drive the global structural heart devices market during the forecast period

Market Research Future (MRFR) has published a cooked research report on the “Structural Heart Devices Market” that contains information from 2018 to 2030. The Structural Heart Devices Market is estimated to register a CAGR of 10.30% during the forecast period of 2023 to 2030.

Structural Heart Devices Market Highlights

The global Structural Heart Devices Market is accounted to register a CAGR of 10.30% during the forecast period and is estimated to reach USD 19.6636 billion by 2030.

The structural heart devices market refers to the medical devices used for the treatment of structural heart diseases. Structural heart diseases are conditions that affect the structure or function of the heart, such as heart valve disorders, congenital heart defects, and diseases of the heart muscle.

Key Players:

MRFR recognizes the following companies as the key players in the global Structural Heart Devices Market — Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), LivaNova plc (UK), ST. Jude Medical, Biomerics, ComedBV, JenaValve Technology Inc., CardioKinetix, and Cook Group Incorporated (US)

Segment Analysis

The global Structural Heart Devices Market has been segmented based Type, Indication, and Procedure.

The Structural Heart Devices market segmentation, based on type, the segment is divided into Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems. Heart Valve Devices Sweeteners segment held the majority share in 2022concerning the Low-Intensity sweeteners market revenue. Due to its established reimbursement codes and therapeutic efficacy.

The Structural Heart Devices market segmentation based on Indication the structural heart devices market has been segmented according to indication into valvular heart disease, cardiomyopathy, congenital heart abnormalities, and others. The two subtypes of valvular heart disease are regurgitation and stenosis. Hence, rising applications of the Segment for biological and tissue valves held a significant market share for structural cardiac devices worldwide. Over the anticipated period, the Segment is likely to dominate the market growth.

The Structural Heart Devices market data has been divided into six categories based on procedure is divided into two categories based on technique replacement process and repair procedure. Throughout the projected period, the replacement procedure segment is expected to account for a sizeable portion of the market due to the availability of cutting-edge technology, & cost-effective treatments.

Explore In-depth Details: Structural Heart Devices Market Research Report

Regional Analysis

The global Structural Heart Devices Market, based on region, has been divided into North America, Europe, Asia-Pacific, and the Rest of the World. The North America Structural Heart device market accounted for USD 4.5 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period. This is attributed to the rate of endovascular procedures has increased as well as invasive procedures across the Region.

Europe's Structural Heart Devices market accounts for the second-largest market share due to indications into valvular heart disease, cardiomyopathy, congenital heart abnormalities, and others. The two subtypes of valvular heart disease are regurgitation and stenosis. Hence, rising applications of the Segment for biological and tissue valves held a significant market share for structural cardiac devices worldwide. Further, the Germany Structural Heart Devices market had the largest market share, and the UK Structural Heart Devices market was the fastest-growing market in the European Region.

The Asia-Pacific Structural Heart Devices Market is expected to grow at the fastest CAGR from 2022 to 2030. This is due to increased rates of cardiovascular disease in the rapidly evolving healthcare industry. Moreover, Japan's Structural Heart Devices market held the largest market share, and the India Structural Heart Devices market was the fastest-growing market in the Asia-Pacific region.

Key Findings of the Study

• The North America Structural Heart device market accounted for USD 4.5 billion in 2022 and is expected to exhibit a significant CAGR growth during the study period.


• The Structural Heart Devices market segmentation, based on type, the segment is divided into Heart Valve Devices, Annuloplasty Rings, Occluders, Delivery Systems.


• Edwards Lifesciences Corporation (US), Medtronic plc (Ireland), Abbott (US), Boston Scientific Corporation (US), LivaNova plc (UK), ST. Jude Medical, Biomerics, ComedBV, JenaValve Technology Inc., CardioKinetix, and Cook Group Incorporated (US).